Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. [electronic resource] by
- Williams, K H
- Viera de Ribeiro, A J
- Prakoso, E
- Veillard, A S
- Shackel, N A
- Bu, Y
- Brooks, B
- Cavanagh, E
- Raleigh, J
- McLennan, S V
- McCaughan, G W
- Bachovchin, W W
- Keane, F M
- Zekry, A
- Twigg, S M
- Gorrell, M D
Producer: 20160104
In:
Diabetes research and clinical practice vol. 108
Availability: No items available.
|